Tempus, a leader in artificial intelligence and precision medicine, announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration...
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced plans to launch two critical solutions for oncology research. These automated...